Susquehanna International Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.31M Buy
2,121,164
+913,922
+76% +$1.33M ﹤0.01% 5065
2025
Q4
$1.39M Buy
1,207,242
+245,182
+25% +$337K ﹤0.01% 6427
2025
Q3
$1.3M Buy
962,060
+206,408
+27% +$234K ﹤0.01% 6713
2025
Q2
$715K Sell
755,652
-195,483
-21% -$127K ﹤0.01% 8308
2025
Q1
$438K Buy
951,135
+400,244
+73% +$253K ﹤0.01% 9186
2024
Q4
$407K Buy
550,891
+463,390
+530% +$559K ﹤0.01% 9173
2024
Q3
$137K Sell
87,501
-26,625
-23% -$47.4K ﹤0.01% 10821
2024
Q2
$192K Buy
114,126
+103,283
+953% +$185K ﹤0.01% 10420
2024
Q1
$26K Sell
10,843
-406,970
-97% -$874K ﹤0.01% 11757
2023
Q4
$639K Buy
417,813
+89,307
+27% +$106K ﹤0.01% 8072
2023
Q3
$358K Sell
328,506
-6,951
-2% -$12.2K ﹤0.01% 8979
2023
Q2
$768K Buy
335,457
+282,164
+529% +$749K ﹤0.01% 7300
2023
Q1
$130K Buy
53,293
+4,438
+9% +$10.2K ﹤0.01% 11054
2022
Q4
$93.3K Sell
48,855
-30,497
-38% -$64.9K ﹤0.01% 11017
2022
Q3
$190K Sell
79,352
-14,599
-16% -$40.4K ﹤0.01% 10920
2022
Q2
$175K Sell
93,951
-21,956
-19% -$41.9K ﹤0.01% 10835
2022
Q1
$242K Sell
115,907
-19,869
-15% -$55.1K ﹤0.01% 10782
2021
Q4
$535K Buy
135,776
+4,427
+3% +$21.5K ﹤0.01% 9009
2021
Q3
$632K Buy
131,349
+91,773
+232% +$377K ﹤0.01% 8783
2021
Q2
$182K Buy
+39,576
New +$191K ﹤0.01% 11688
2021
Q1
Sell
-89,796
Closed -$622K 12684
2020
Q4
$307K Buy
+89,796
New +$171K ﹤0.01% 9202
2020
Q3
Sell
-56,442
Closed -$100K 11008
2020
Q2
$113K Buy
56,442
+37,266
+194% +$73K ﹤0.01% 9436
2020
Q1
$37K Sell
19,176
-40,259
-68% -$120K ﹤0.01% 9773
2019
Q4
$247K Buy
59,435
+40,308
+211% +$155K ﹤0.01% 8379
2019
Q3
$58K Sell
19,127
-12,975
-40% -$40.2K ﹤0.01% 9738
2019
Q2
$202K Sell
32,102
-95,050
-75% -$569K ﹤0.01% 9103
2019
Q1
$707K Buy
127,152
+29,674
+30% +$180K ﹤0.01% 5655
2018
Q4
$647K Buy
+97,478
New +$790K ﹤0.01% 5522
2018
Q3
Sell
-33,871
Closed -$388K 10173
2018
Q2
$406K Buy
33,871
+13,668
+68% +$140K ﹤0.01% 7219
2018
Q1
$173K Sell
20,203
-34,259
-63% -$317K ﹤0.01% 8432
2017
Q4
$538K Buy
54,462
+9,406
+21% +$97.7K ﹤0.01% 6492
2017
Q3
$554K Sell
45,056
-379,761
-89% -$5.61M ﹤0.01% 6346
2017
Q2
$6.99M Buy
+424,817
New +$6.58M 0.03% 2021
2017
Q1
Sell
-267,946
Closed -$3.98M 9686
2016
Q4
$3.71M Buy
267,946
+152,200
+131% +$2.44M 0.02% 2909
2016
Q3
$2.09M Buy
+115,746
New +$1.86M 0.01% 3500
2016
Q2
Sell
-30,406
Closed -$412K 9153
2016
Q1
$363K Buy
+30,406
New +$319K ﹤0.01% 6939
2015
Q4
Sell
-93,501
Closed -$1.15M 9790
2015
Q3
$1M Buy
93,501
+82,951
+786% +$906K ﹤0.01% 5749
2015
Q2
$85K Buy
10,550
+8,929
+551% +$65.6K ﹤0.01% 9731
2015
Q1
$11K Sell
1,621
-32,548
-95% -$222K ﹤0.01% 9304
2014
Q4
$218K Buy
+34,169
New +$275K ﹤0.01% 8663
2014
Q3
Sell
-17,674
Closed -$199K 9764
2014
Q2
$199K Buy
17,674
+2,686
+18% +$28.9K ﹤0.01% 9081
2014
Q1
$181K Sell
14,988
-299
-2% -$3.82K ﹤0.01% 8306
2013
Q4
$193K Buy
15,287
+518
+4% +$8.24K ﹤0.01% 8301
2013
Q3
$245K Buy
14,769
+12,307
+500% +$206K ﹤0.01% 7494
2013
Q2
$37K Buy
+2,462
New +$37.4K ﹤0.01% 8028

Other funds holding LXRX